-
EP3102575
European procedure
Extract from the Register of European Patents
EP About this file: EP3102575
| EP3102575 - NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 19.11.2021 Database last updated on 19.05.2026 | |
| Former | The patent has been granted Status updated on 11.12.2020 | ||
| Former | Grant of patent is intended Status updated on 04.08.2020 | ||
| Former | Examination is in progress Status updated on 15.06.2020 | ||
| Former | Grant of patent is intended Status updated on 24.02.2020 | ||
| Former | Examination is in progress Status updated on 07.05.2019 | ||
| Former | Request for examination was made Status updated on 11.11.2016 | Most recent event Tooltip | 19.11.2021 | No opposition filed within time limit | published on 22.12.2021 [2021/51] | Applicant(s) | For all designated states Galapagos NV Generaal De Wittelaan L11/A3 2800 Mechelen / BE | [2016/50] | Inventor(s) | 01 /
SABOURAULT, Nicolas Luc Galapagos SASU 102 Avenue Gaston Roussel F-93230 Romainville / FR | 02 /
DE FAVERI, Carla Lundbeck Pharmaceuticals Italy SpA Quarta Strada 2 I-35129 Padova / IT | 03 /
SHEIKH, Ahmad AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US | [2016/50] | Representative(s) | Bar, Grégory Galapagos NV IP Department Generaal De Wittelaan, L11 A3 2800 Mechelen / BE | [2016/50] | Application number, filing date | 15704974.3 | 04.02.2015 | [2016/50] | WO2015EP52242 | Priority number, date | GB20140002071 | 07.02.2014 Original published format: GB 201402071 | [2016/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015117981 | Date: | 13.08.2015 | Language: | EN | [2015/32] | Type: | A1 Application with search report | No.: | EP3102575 | Date: | 14.12.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.08.2015 takes the place of the publication of the European patent application. | [2016/50] | Type: | B1 Patent specification | No.: | EP3102575 | Date: | 13.01.2021 | Language: | EN | [2021/02] | Search report(s) | International search report - published on: | EP | 13.08.2015 | Classification | IPC: | A61P19/00, A61P19/02, A61P29/00, A61P35/00, A61P37/00, A61P37/06, A61P37/08, H04L29/08, H04W4/80, H04W8/24, H04W92/18, C07D471/04, A61K31/541, A61P43/00, H04L29/06 | [2020/34] | CPC: |
C07D471/04 (EP,EA,IL,KR,US);
A61K31/437 (EA,IL,KR,US);
A61K31/541 (EP,EA,IL,KR,US);
A61K45/06 (EA,KR,US);
A61P19/00 (EP,EA);
A61P19/02 (EP);
A61P29/00 (EP,EA);
A61P35/00 (EP,EA);
A61P37/00 (EP);
A61P37/06 (EP,EA);
A61P37/08 (EP,EA);
A61P43/00 (EP);
C07D417/10 (IL,KR);
H04L63/0428 (EP,US);
H04L63/06 (EP,US);
H04L63/0861 (EP,US);
H04L63/205 (EP,US);
H04L67/104 (EP,US);
H04L67/51 (EP,US);
H04W4/80 (EP,US);
H04W8/24 (EP,US);
|
| Former IPC [2020/10] | A61K31/541, C07D471/04 | ||
| Former IPC [2016/50] | C07D471/04, A61K31/437 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/50] | Extension states | BA | 01.09.2016 | ME | 01.09.2016 | Title | German: | NEUE SALZE UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DAVON ZUR BEHANDLUNG VON ENTZÜNDLICHEN BESCHWERDEN | [2020/10] | English: | NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS | [2016/50] | French: | NOUVEAUX SELS ET COMPOSITIONS PHARMACEUTIQUES ASSOCIÉES POUR LE TRAITEMENT DE TROUBLES INFLAMMATOIRES | [2016/50] |
| Former [2016/50] | NEUARTIGE SALZE UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DAVON ZUR BEHANDLUNG VON ENTZÜNDUNGSERKRANKUNGEN | Entry into regional phase | 01.09.2016 | National basic fee paid | 01.09.2016 | Designation fee(s) paid | 01.09.2016 | Examination fee paid | Examination procedure | 01.09.2016 | Examination requested [2016/50] | 01.09.2016 | Date on which the examining division has become responsible | 05.04.2017 | Amendment by applicant (claims and/or description) | 10.05.2019 | Despatch of a communication from the examining division (Time limit: M06) | 06.11.2019 | Reply to a communication from the examining division | 25.02.2020 | Communication of intention to grant the patent | 10.06.2020 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 05.08.2020 | Communication of intention to grant the patent | 03.12.2020 | Fee for grant paid | 03.12.2020 | Fee for publishing/printing paid | 03.12.2020 | Receipt of the translation of the claim(s) | Divisional application(s) | EP20211405.4 / EP3842432 | Opposition(s) | 14.10.2021 | No opposition filed within time limit [2021/51] | Fees paid | Renewal fee | 10.02.2017 | Renewal fee patent year 03 | 14.02.2018 | Renewal fee patent year 04 | 13.02.2019 | Renewal fee patent year 05 | 13.02.2020 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XAY] WO2010149769 (GALAPAGOS NV et al.) [X] 1-4,9-11 * paragraphs [0033] , [0035]; claims 1-10 *[A] 5-8,15 [Y] 9-14 | [XAYI] WO2013189771 (GALAPAGOS NV et al.) [X] 9 * paragraphs [0165] , [0166]; claims 8,11 *[A] 5-8,15 [Y] 9-14 [I] 10 |